These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11604432)

  • 1. Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort.
    Taylor RJ; Morrell SL; Mamoon HA; Wain GV
    J Epidemiol Community Health; 2001 Nov; 55(11):782-8. PubMed ID: 11604432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age--period--cohort approach.
    Woo PP; Thach TQ; Choy ST; McGhee SM; Leung GM
    Br J Cancer; 2005 Oct; 93(9):1077-83. PubMed ID: 16205695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projections of cervical cancer mortality and incidence in New Zealand: the possible impact of screening.
    Cox B; Skegg DC
    J Epidemiol Community Health; 1992 Aug; 46(4):373-7. PubMed ID: 1431710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
    Taylor R; Morrell S; Mamoon H; Wain G; Ross J
    Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of screening on cervical cancer incidence in England: a time trend analysis.
    Pesola F; Sasieni P
    BMJ Open; 2019 Jan; 9(1):e026292. PubMed ID: 30679300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
    Macgregor JE; Campbell MK; Mann EM; Swanson KY
    BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia.
    Aminisani N; Armstrong BK; Egger S; Canfell K
    BMC Cancer; 2012 Oct; 12():491. PubMed ID: 23092207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006.
    Foley G; Alston R; Geraci M; Brabin L; Kitchener H; Birch J
    Br J Cancer; 2011 Jun; 105(1):177-84. PubMed ID: 21654675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening.
    Taylor R; Boyages J
    J Med Screen; 2001; 8(2):73-6. PubMed ID: 11480447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific differences in cervical cancer screening rates in women using mental health services in New South Wales, Australia.
    Impelido ML; Brewer K; Burgess P; Curtis J; Currow D; Sara G
    Aust N Z J Psychiatry; 2024 Oct; 58(10):885-891. PubMed ID: 38095076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the effects of the age-period-birth cohort on cervical cancer mortality in the Brazilian Northeast.
    Meira KC; Silva GWDS; Dos Santos J; Guimarães RM; de Souza DLB; Ribeiro GPC; Dantas ESO; Carvalho JBL; Jomar RT; Simões TC
    PLoS One; 2020; 15(2):e0226258. PubMed ID: 32074101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cervical cancer epidemic that screening has prevented in the UK.
    Peto J; Gilham C; Fletcher O; Matthews FE
    Lancet; 2004 Jul 17-23; 364(9430):249-56. PubMed ID: 15262102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
    Kind AB; Pavelyev A; Kothari S; El Mouaddin N; Schmidt A; Morais E; Guggisberg P; Lienert F
    BMC Public Health; 2020 May; 20(1):671. PubMed ID: 32398057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.
    Simms KT; Hanley SJB; Smith MA; Keane A; Canfell K
    Lancet Public Health; 2020 Apr; 5(4):e223-e234. PubMed ID: 32057317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pap smear screening and changes in cervical cancer mortality in Sweden.
    Mählck CG; Jonsson H; Lenner P
    Int J Gynaecol Obstet; 1994 Mar; 44(3):267-72. PubMed ID: 7909766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States.
    Hosier H; Sheth SS; Oliveira CR; Perley LE; Vash-Margita A
    Am J Obstet Gynecol; 2021 Dec; 225(6):649.e1-649.e9. PubMed ID: 34256029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
    Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
    BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.